Cann Group Limited (FRA:CVJ)

Market Cap	4.01M -24.4%
Revenue (ttm)	6.42M -27.1%
Net Income	8.37M
EPS	0.01
Shares Out	n/a
PE Ratio	0.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0005
Previous Close	0.0005
Day's Range	0.0005 - 0.0005
52-Week Range	0.0002 - 0.0130
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 4, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

• Industry: Pharmaceutical Preparations
• Founded: 2014
• Country: Australia
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVJ

Financial Performance

In fiscal year 2025, Cann Group's revenue was 13.25 million, a decrease of -27.81% compared to the previous year's 18.36 million. Losses were -22.35 million, -56.39% less than in 2024.

Financial numbers in AUD